Algorithm for Apherisis Monitoring and Prescription Assistance in Sickle Cell Patients (ALGODREP)

NCT04076683 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DEVICE: Algodrep

Sponsor

Etablissement Français du Sang

Collaborators

[object Object]
[object Object]